相似文献
1
RNA respiratory viral infections in solid organ transplant recipients.
Am J Transplant. 2009 Dec;9 Suppl 4(Suppl 4):S166-72. doi: 10.1111/j.1600-6143.2009.02908.x.
2
Community respiratory viruses: organ transplant recipients.
Am J Med. 1997 Mar 17;102(3A):31-6; discussion 42-3. doi: 10.1016/s0002-9343(97)80008-3.
3
Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy.
Crit Care Nurs Q. 2017 Oct/Dec;40(4):399-413. doi: 10.1097/CNQ.0000000000000176.
4
Cutaneous infections from viral sources in solid organ transplant recipients.
J Clin Virol. 2017 Dec;97:33-37. doi: 10.1016/j.jcv.2017.08.007. Epub 2017 Aug 18.
5
RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Clin Transplant. 2019 Sep;33(9):e13511. doi: 10.1111/ctr.13511. Epub 2019 Mar 22.
6
Respiratory viral infections in transplant recipients.
Antivir Ther. 2007;12(4 Pt B):627-38.
7
Respiratory Viruses in Solid Organ Transplant Recipients.
Viruses. 2021 Oct 25;13(11):2146. doi: 10.3390/v13112146.
8
Respiratory virus infections in bone marrow transplant recipients: the European perspective.
Am J Med. 1997 Mar 17;102(3A):44-7. doi: 10.1016/s0002-9343(97)00010-7.
9
Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.
Bone Marrow Transplant. 2003 Jul;32(1):73-7. doi: 10.1038/sj.bmt.1704048.
10
Emerging fungal infections in solid organ transplant recipients: Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Clin Transplant. 2019 Sep;33(9):e13525. doi: 10.1111/ctr.13525. Epub 2019 Apr 10.
引用本文的文献
1
Advances in development of antiviral strategies against respiratory syncytial virus.
Acta Pharm Sin B. 2025 Apr;15(4):1752-1772. doi: 10.1016/j.apsb.2025.02.015. Epub 2025 Feb 20.
2
Correlation of clinical, laboratory, and short-term outcomes of immunocompromised and immunocompetent COVID-19 patients with semi-quantitative chest CT score findings: A case-control study.
Immun Inflamm Dis. 2024 Apr;12(4):e1239. doi: 10.1002/iid3.1239.
3
Three Consequent Pediatric Liver Transplant Deaths in the COVID-19 Era.
Int J Organ Transplant Med. 2020;11(4):202-206.
4
Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection.
Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1581-1592. doi: 10.1007/s10096-020-03878-9. Epub 2020 May 27.
5
Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation.
Semin Nephrol. 2016 Sep;36(5):417-427. doi: 10.1016/j.semnephrol.2016.05.018.
6
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Eur J Cancer. 2016 Nov;67:200-212. doi: 10.1016/j.ejca.2016.08.015. Epub 2016 Sep 25.
7
Clinical evaluation of a multi-parameter customized respiratory TaqMan(®) array card compared to conventional methods in immunocompromised patients.
J Clin Virol. 2015 Nov;72:36-41. doi: 10.1016/j.jcv.2015.08.022. Epub 2015 Sep 3.
8
Respiratory syncytial virus pneumonia treated with lower-dose palivizumab in a heart transplant recipient.
Case Rep Cardiol. 2012;2012:723407. doi: 10.1155/2012/723407. Epub 2011 Oct 27.
9
Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia.
PLoS One. 2014 Apr 21;9(4):e95865. doi: 10.1371/journal.pone.0095865. eCollection 2014.
10
Minimizing infection risks after paediatric organ transplants: Advice for practitioners.
Paediatr Child Health. 2013 Mar;18(3):143-54.
本文引用的文献
1
Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
J Heart Lung Transplant. 2009 Jan;28(1):67-71. doi: 10.1016/j.healun.2008.10.008.
2
Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers.
Pediatr Transplant. 2009 Jun;13(4):451-6. doi: 10.1111/j.1399-3046.2008.01017.x. Epub 2008 Sep 10.
3
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60.
4
Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.
Am J Respir Crit Care Med. 2008 Oct 15;178(8):876-81. doi: 10.1164/rccm.200711-1657OC. Epub 2008 Jul 24.
5
Outcome of influenza infection managed with oseltamivir in lung transplant recipients.
J Heart Lung Transplant. 2008 Mar;27(3):282-8. doi: 10.1016/j.healun.2007.11.575.
6
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164. doi: 10.1016/j.ajic.2007.10.007.
7
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Pediatr Infect Dis J. 2007 Dec;26(12):1089-93. doi: 10.1097/INF.0b013e3181343b7e.
8
Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.
Transplantation. 2007 Oct 15;84(7):851-6. doi: 10.1097/01.tp.0000282788.70383.8b.
9
Respiratory viral infections in transplant recipients.
Antivir Ther. 2007;12(4 Pt B):627-38.
10
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.
J Heart Lung Transplant. 2007 Aug;26(8):862-4. doi: 10.1016/j.healun.2007.05.020. Epub 2007 Jul 12.
Zotero 插件